Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Hypertension, Uncontrolled Hypertension

In brief

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

Key facts

Study ID
NCT07090161
Run by
Vanda Pharmaceuticals
People needed
240
Starts
2025-09-15
Expected to finish
2026-11-01
Last updated by the study team
2026-02-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.